In acute myeloid leukemia (AML), the increased expression and phosphorylation of eIF4E are associated with poor prognosis, and phosphorylated eIF4E can be used as a prognostic indicator and potential anti-cancer target for biological therapy of AML (147, 148). Here, EIF4E is linked to cancer.